Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Anti-Nuclear Antibodies & Nuclear Molecules in Systemic Lupus Erythematosus

Katie Robinson  |  September 6, 2024

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that primarily affects young women and causes a wide range of inflammatory manifestations. Its hallmark is the production of antibodies to components of the cell nucleus (anti-nuclear antibodies [ANAs]). …

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:ANAanti-neutrophil antibodyImmunologySLE Resource Center

ACR Offers Resources & Personalized Help for Practice Management Questions

From the College  |  August 19, 2024

ACR staff can help members navigate questions on all areas of practice management.

Filed under:Practice ManagementPractice Support Tagged with:Member benefits

Heading to D.C. for ACR Convergence 2024? Add Your Lawmakers to Your Itinerary

From the College  |  August 19, 2024

If you’re headed to Washington, D.C., this November for ACR Convergence 2024, plan now to schedule meetings with your members of Congress. Your voice as a constituent can help your lawmakers understand which policies are good for healthcare as they consider a critical end-of-year funding package.

Filed under:Legislation & Advocacy Tagged with:ACR Convergence 2024

Calling Young Rheumatologist Leaders

From the College  |  August 17, 2024

The ACR is seeking a representative to the Young Physician Section of the AMA House of Delegates who will join the ACR’s delegation at future HOD meetings and advance issues important to rheumatology.

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:AMA House of Delegates (HOD)

What’s New in Large Vessel Vasculitis

Philip Seo, MD, MHS  |  August 7, 2024

The large vessel vasculitides were a major focus of the 21st International Vasculitis Workshop held in Barcelona in April. The biennial conference brings together specialists from multiple disciplines, including rheumatology, nephrology and immunology, to discuss cutting-edge vasculitis research. This article reviews important points regarding the pathogenesis, diagnosis and management of both giant cell arteritis and…

Filed under:ConditionsGuidanceResearch ReviewsResearch RheumVasculitis Tagged with:diverticulitisgastrointestinal perforationGiant Cell Arteritisgiant cell arteritis (GCA)interleukin-17A inhibitorlarge-vessel vasculitisTakayasu arteritis (TAK)Takayasu’s Arteritistocilizumab

Summer 2024’s Awards, Appointments & Announcements in the World of Rheumatology

Gretchen Henkel  |  August 7, 2024

Dr. Megan Cooper Appointed Director of Pediatric Rheumatology & Immunology Division at WashU Megan A. Cooper, MD, PhD, a physician-scientist recognized internationally for her work in pediatric immunodeficiencies and immune dysregulation, took the reins of the Division of Pediatric Rheumatology and Immunology at Washington University School of Medicine, St. Louis, as director this past fall….

Filed under:AwardsAwardsCareer Tagged with:Dr. Julie CampbellDr. Megan A. CooperDr. Mitchell D. FormanMovers & Shakers

AWIR & ACR: Building a Strong Future Rheumatology Community

Joseph Cantrell, JD  |  August 6, 2024

The ACR was fortunate to participate in the Association for Women in Rheumatology’s 2024 Annual Meeting in Orlando. As this relationship grows every year, the AWIR and ACR are working together to build a sustainable and inclusive rheumatology community for the future.

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Association of Women in Rheumatology (AWIR)

What Is Procrastination, & How Can We Beat It?

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  August 6, 2024

There’s a Word file—somewhere—on one of the many flash drives jumbled in a drawer in my home office. That file is named something like “Overcoming_Procrastination_Column.docx” and was last accessed in the year 2018. I know I wrote about 500 words, and then, one day, I said I would finish it later. But I never did….

Filed under:OpinionRheuminations

Helping Patients with SLE Thrive

Jason Liebowitz, MD, FACR  |  July 31, 2024

Dr. Laurent Arnaud highlighted the latest information on systemic lupus erythematosus (SLE), including genetics, technology, treat to target, and promising findings for pulse therapy in his session at EULAR 2024.

Filed under:ConditionsEULAR/OtherGuidanceMeeting ReportsSystemic Lupus Erythematosus Tagged with:EULAR 2024Lupus Low Disease-Activity State (LLDAS)SLESLE Resource Centersystemic lupus erythematosus (SLE)

What’s New in Polymyalgia Rheumatica?

Jason Liebowitz, MD, FACR  |  July 31, 2024

Should all patients with polymyalgia rheumatica (PMR) have a vascular ultrasound assessment? What treatments are the safest and most efficacious for patients with PMR? Frank Buttgereit, MD, answered these questions and highlighted the latest research on PMR in this session at EULAR 2024.

Filed under:ConditionsEULAR/OtherGuidanceMeeting ReportsPain Syndromes Tagged with:EULAR 2024GCAgiant cell arteritis (GCA)PMRPolymyalgia Rheumatica

  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 329
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences